ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,736.82
      1.46%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CV Therapeutics (MM) (CVTX)

      7. CV Therapeutics (MM) (CVTX) News

      CVTX

      CV Therapeutics (CVTX)

      CV Therapeutics (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CVTX
      DateTimeSourceHeadlineSymbolCompany
      12/15/20084:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/15/20084:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/15/20084:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/12/200810:43AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
      12/10/20085:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/10/20085:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/10/20085:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/10/20085:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/10/20085:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/05/20081:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      12/04/20084:01PMMarketwiredCV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350NASDAQ:CVTXCV Therapeutics (MM)
      11/11/200811:51AMPR Newswire (US)Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: CCE, KSS, CVTX, SLG, LPNT, TEFNASDAQ:CVTXCV Therapeutics (MM)
      11/07/20081:00PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CVTXCV Therapeutics (MM)
      11/06/20083:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      11/06/20086:08AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      11/06/20086:02AMPR Newswire (US)CV Therapeutics Reports 2008 Third Quarter Financial ResultsNASDAQ:CVTXCV Therapeutics (MM)
      11/06/20086:00AMPR Newswire (US)FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, BradycardiaNASDAQ:CVTXCV Therapeutics (MM)
      10/23/20088:30AMPR Newswire (US)CV Therapeutics to Announce 2008 Third Quarter Financial Results on Thursday, November 6, 2008NASDAQ:CVTXCV Therapeutics (MM)
      10/21/20088:30AMPR Newswire (US)CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008NASDAQ:CVTXCV Therapeutics (MM)
      10/15/20083:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      10/09/20081:45PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CVTXCV Therapeutics (MM)
      09/18/20086:02AMEdgar (US Regulatory)CV Therapeutics Inc - Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      09/12/20086:00AMPR Newswire (US)CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini GroupNASDAQ:CVTXCV Therapeutics (MM)
      09/10/20086:02AMEdgar (US Regulatory)CV Therapeutics Inc - Statement of Ownership (SC 13G)NASDAQ:CVTXCV Therapeutics (MM)
      09/09/20082:21PMEdgar (US Regulatory)CV Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      09/02/20088:30AMPR Newswire (US)CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic DiseasesNASDAQ:CVTXCV Therapeutics (MM)
      08/27/20084:01PMPR Newswire (US)CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350NASDAQ:CVTXCV Therapeutics (MM)
      08/27/200810:16AMEdgar (US Regulatory)CV Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:CVTXCV Therapeutics (MM)
      08/20/20081:23PMEdgar (US Regulatory)CV Therapeutics Inc - Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      08/19/20088:30AMPR Newswire (US)Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac RelaxatNASDAQ:CVTXCV Therapeutics (MM)
       Showing the most relevant articles for your search:NASDAQ:CVTX